Numerous studies have established the oncogenic roles of VHL/HIF-1α and SOCS/JAK-STAT pathways in regulating leukemia cell growth and hematological malignancies (Labno-Kirszniok et al., 2013; Moura et al., 2018). Here, HIF1A is linked to hematologic disorder.